Showing 4 of 4 recruiting trials for “Myelodysplastic/myeloproliferative disease”
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
A Study Using Subject-specific MRD to Adopt Treatment After HSCT for Subjects With MDS
CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →